Loading stock data…
Prenetics Global Limited (PRE)
$25.62+0.18 (+0.71%)
Market ClosedLast close Sep 8
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Prenetics Global Limited in the Consumer Defensive sector is trading at $25.62 with a market capitalization of $430M. Wall Street consensus targets $35.17 (6 analysts), implying a +37.3% move over the next 12 months. The stock is currently near its 52-week high of $27.24, remaining 38.6% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +37.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $35.95M↓ | $36.56M↑ | $23.55M↑ | $17.68M↑ | $8.28M |
| Gross Profit | $23.28M↑ | $21.59M↑ | $14.02M↑ | $7.29M↑ | $5.61M |
| Operating Income | -$9.71M↑ | -$13.14M↓ | -$6.56M↑ | -$9.87M↓ | -$6.17M |
| Net Income | -$23.10M↓ | -$7.50M↓ | -$7.41M↑ | -$12.41M↓ | -$10.39M |
Peer Comparison
Fundamentals
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer g...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$429.89M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.31
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-50.53%
Volume
Today's trading volume
157,890
Recent News
Prenetics Global Ltd (PRE) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ...
Prenetics Global Ltd (PRE) reports sixth consecutive record quarter with revenue up 3.9x year-over-year, raises full-year guidance, and achieves first month of positive adjusted free cash flow.
Prenetics Global Limited Q2 2026 Earnings Call Summary
Moby summary of Prenetics Global Limited's Q2 2026 earnings call
Prenetics Global Q2 Earnings Call Highlights
Prenetics Global (NASDAQ:PRE) reported second-quarter revenue of $46.5 million, up 29% sequentially and about 3.9 times from a year earlier, as its IM8 supplement business continued to add subscribers and scale marketing spending. The company raised its full-year revenue outlook and said July marked
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
Prenetics will host a live earnings webcast at 8:30 a.m. Eastern time today to discuss the results. A replay will be made available on the Investor Relations website following the call. NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham, today reported its second quarter 2026 financial results.
Sector Update: Healthcare Stocks Fall Late Afternoon
Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the